Valuation: Getinge AB

Market Cap 64.93B 6.85B 5.93B 5.53B 5.09B 9.6B 651B 9.71B 25.46B 326B 25.72B 25.15B 1,088B P/E 2026 *
21x
P/E 2027 * 18.7x
Enterprise Value 73.49B 7.75B 6.71B 6.25B 5.76B 10.86B 737B 10.98B 28.82B 369B 29.11B 28.46B 1,232B EV / Sales 2026 *
2.09x
EV / Sales 2027 * 1.92x
Free-Float
78.61%
Yield 2026 *
2.18%
Yield 2027 * 2.36%
1 day+12.17%
1 month+12.17%
3 months-3.19%
6 months-9.13%
Current year+1.76%
1 month 22.49
Extreme 22.49
22.49
Current year 20.05
Extreme 20.05
24.75
1 year 20.05
Extreme 20.05
24.75
3 years 15.62
Extreme 15.62
24.75
5 years 15.62
Extreme 15.62
48.01
10 years 8.75
Extreme 8.75
48.01
Manager TitleAgeSince
Chief Executive Officer 54 2017-04-30
Director of Finance/CFO 48 2024-03-30
Compliance Officer 47 2020-09-30
Director TitleAgeSince
Chairman 65 2019-04-22
Chairman 75 -
Director/Board Member 70 2006-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+12.17%-.--% - - 6.84B
-0.31%+1.01%+34.45%+28.07% 12.77B
+1.17%+1.90%+54.12%+28.42% 6.06B
-2.26%+5.22% - - 5.33B
-0.48%+0.91%-23.60%+39.21% 4.52B
-0.86%+2.49%-21.68%-19.05% 4.11B
-1.35%-1.59%+36.48%-43.78% 1.89B
0.00%+2.23%-21.71%+195.29% 1.77B
+1.78%+2.27%+62.37%-2.63% 1.63B
0.00%+5.93%-30.55%-49.27% 1.28B
Average +0.99%+1.38%+11.24%+22.03% 4.37B
Weighted average by Cap. +1.49%+1.41%+19.55%+24.21%

Financials

2026 *2027 *
Net sales 35.16B 3.71B 3.21B 2.99B 2.75B 5.2B 353B 5.26B 13.79B 177B 13.93B 13.62B 589B 37.08B 3.91B 3.38B 3.16B 2.9B 5.48B 372B 5.54B 14.54B 186B 14.69B 14.36B 622B
Net income 3.09B 325M 282M 263M 242M 456M 30.95B 461M 1.21B 15.5B 1.22B 1.2B 51.73B 3.46B 365M 315M 294M 271M 511M 34.67B 517M 1.36B 17.36B 1.37B 1.34B 57.95B
Net Debt 8.56B 903M 781M 729M 670M 1.27B 85.86B 1.28B 3.36B 43B 3.39B 3.32B 143B 6.33B 667M 577M 539M 496M 935M 63.47B 946M 2.48B 31.78B 2.51B 2.45B 106B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,758
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
238.40SEK
Average target price
237.90SEK
Spread / Average Target
-0.21%

Quarterly revenue - Rate of surprise